Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for the Patients with Hepatocellular Carcinoma beyond Up-to 7 Criteria - RAIB-TACE for the Patients with Hepatocellular Carcinoma beyond Up-to 7 Criteria

Hoshiai Sodai0 个研究点目标入组 19 人开始时间: 2021年1月29日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1) Child-Pugh score is greater than or equal to 7.
•2) Renal function with an eGFR of less than 40.
•3) Tumor throat in portal vein branch or main stem or hepatic vein.
•4) The largest tumor is greater than or equal to 15 cm in diameter.
•5) Sarcomatous changes (over the course of 2-3 months, the tumor size increases 1.5-2 times or more in size and there is no increase in arterial blood flow. Alternatively, there is a ring of staining with irregular margins and no capsule structure and internal necrosis.
•6) Lymph node involvement or distant metastasis.
•7) Previous surgical biliary reconstruction or endoscopic bile duct treatment.
•8) Dilation of bile ducts larger than the diameter of the accompanying portal vein at the level of the area or higher.
•9) A severe arterial-portal or arterial-venous shunt is present.
•10) Severe mental impairment.
•11) Severe allergy to iodine contrast medium or other drugs.
•12) Pregnant or lactating patients.
•13) Other patients who are deemed unsuitable as subjects by the investigator (or subspecialist).
•14) Previous radiation therapy for hepatocellular carcinoma.

发起方

Hoshiai Sodai